Catheter

Medical Polymers Market Size to Grow USD 21320 Million by 2029 at a CAGR of 3.1% | Valuates Reports

Retrieved on: 
Wednesday, February 7, 2024
Polymer, Stent, Regenerative medicine, Conditional sentence, Biomaterial, Catheter, Ageing, Packaging and labeling, DSM, Polyethylene, PVC, Incidence, Tissue engineering, Biodegradable plastic, Polyvinyl chloride, Medical device, Diabetes, Administration, Risk, Cancer, Equipment, BASF

BANGALORE, India , Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).

Key Points: 
  • BANGALORE, India , Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).
  • The growing need for biocompatible materials in the healthcare industry is driving the expansion of the medical polymers market.
  • Biocompatible polymers, including polyethylene, polypropylene , and polyvinyl chloride (PVC) , find widespread application in drug delivery systems, implants, and medical devices.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18T15867...
    The top companies in the worldwide market for medical polymers include BASF SE, Bayer, Celanese, DSM, Du Pont, and others.

Medical Polymers Market Size to Grow USD 21320 Million by 2029 at a CAGR of 3.1% | Valuates Reports

Retrieved on: 
Wednesday, February 7, 2024
Polymer, Stent, Regenerative medicine, Conditional sentence, Biomaterial, Catheter, Ageing, Packaging and labeling, DSM, Polyethylene, PVC, Incidence, Tissue engineering, Biodegradable plastic, Polyvinyl chloride, Medical device, Diabetes, Administration, Risk, Cancer, Equipment, BASF

BANGALORE, India, Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).

Key Points: 
  • BANGALORE, India, Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).
  • The growing need for biocompatible materials in the healthcare industry is driving the expansion of the medical polymers market.
  • Biocompatible polymers, including polyethylene, polypropylene , and polyvinyl chloride (PVC) , find widespread application in drug delivery systems, implants, and medical devices.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18T15867...
    The top companies in the worldwide market for medical polymers include BASF SE, Bayer, Celanese, DSM, Du Pont, and others.

Prytime Medical Announces Donation of $1.75 Million of Medical Aid and Training to Ukraine to Fill Gap Until Non-Lethal Medical Aid Approved by US Government

Retrieved on: 
Tuesday, February 6, 2024
SAN, Military, Bandage, Tourniquet, Patient, Safety, Catheter, Physician, Bleeding, Learning, REBOA, Death, Medical device

SAN ANTONIO, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Prytime Medical Devices Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for minimally invasive, endovascular hemorrhage control, announced the donation of significant non-lethal medical products and training valued over $1,750,000 to Ukraine.

Key Points: 
  • The key challenge my field surgeons face is transporting bleeding soldiers to a safe field hospital where we can save their lives.
  • "The key challenge my field surgeons face is transporting bleeding soldiers to a safe field hospital where we can save their lives.
  • That's why it has been my top priority to get REBOA included in the non-lethal medical aid package from the United States.
  • The use in Ukraine shows that it can also be used to safely transport the bleeding wounded off the battlefield.

Electronic adhesives by Meridian EPO-TEK® highlighted at MD&M West

Retrieved on: 
Monday, February 5, 2024
Ultrasound, Electronics, CGMS, UV, MD, PZT, MED, ISO, Temperature, Commercial, Catheter, Anaheim Convention Center, Endoscopy, PCB, Medical device

CHARLOTTE, N.C., Feb. 5, 2024 /PRNewswire-PRWeb/ -- Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center.

Key Points: 
  • Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center
    CHARLOTTE, N.C., Feb. 5, 2024 /PRNewswire-PRWeb/ -- Meridian Adhesives Group (Meridian) will feature EPO-TEK®'s advanced adhesive solutions for medical electronic applications at booth 531 at the MD&M West Show from Feb. 6-8 at the Anaheim Convention Center.
  • The company's biocompatible/medical device grade adhesives are available in room temperature two-part systems or pre-mixed frozen single-component syringes.
  • Meridian will also highlight the EPO-TEK® "MED" line, which includes EPO-TEK® Biocompatible Medical Device Grade Products.
  • As a global manufacturer and custom formulator specializing in epoxy and UV adhesives, its focus is on medical device applications.

New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients

Retrieved on: 
Wednesday, January 31, 2024
ICU, Surgeon, PHG, Workflow, Heart, Ventricular septal defect, AI, Catheter, 3D, Patient, Twilight anesthesia, Diagnosis, TEE, FDA, Columbia University, Mini, Echocardiography, Society, Physician, Risk, Cardiology, AEX, Detection, EPIQ, Medical imaging

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.

Key Points: 
  • Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.
  • Announced today, Philips’ new X11-4t Mini 3D TEE transducer is shifting that balance and opening 3D TEE imaging to previously unaddressed patients [5].
  • “As a pioneer and leading innovator in cardiac ultrasound, our 3D ultrasound technology plays a critical role in many cardiac procedures.
  • The Philips X11-4t ultrasound transducer is scheduled for commercial availability in 2024 and is pending CE mark in Europe.

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium

Retrieved on: 
Wednesday, January 31, 2024
Biotechnology, Health Technology, Health, Medical Devices, Cardiology, Mount Sinai Hospital, Catheter, Safety, PFA, Atrial fibrillation, Medical device

The session will include a presentation on the latest developments in Nanosecond Pulsed Field (nsPFA) technology, specifically highlighting the preliminary findings from the Company’s CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study.

Key Points: 
  • The session will include a presentation on the latest developments in Nanosecond Pulsed Field (nsPFA) technology, specifically highlighting the preliminary findings from the Company’s CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study.
  • "I look forward to presenting one of our initial cases with this promising technology at the AF Symposium and am honored to be part of the team to perform the first-in-human procedures with the CellFX nsPFA 360 Cardiac Catheter," said Dr. Vivek Reddy.
  • "The circumferential footprint and flexible structure of the 360 nsPFA catheter has been extremely fast and versatile in these initial procedures, setting it apart from many other PFA catheters.
  • We look forward to completing enrollment in this study to fully assess the safety and durability of this next generation PFA technology."

Ascend to showcase health care innovations at MD&M West

Retrieved on: 
Friday, February 2, 2024
Suture, Booth, MD, Ascend, Caregiver, Safety, Medicine, Instrument, Splints, Catheter, Skin, Metal, Patient, Medtech

HOUSTON, Feb. 2, 2024 /PRNewswire/ -- Ascend Performance Materials will introduce new products from its expanding health care brands, Acteev MED™ and HiDura® MED, at the Medical Design & Manufacturing West show next week in Anaheim, California. It is the first time the company has exhibited its longstanding medical business at the show.

Key Points: 
  • It is the first time the company has exhibited its longstanding medical business at the show.
  • Our materials feel soothing without sacrificing performance
    Ascend's medical business and technology experts will showcase novel and traditional solutions for medical durables, packaging, surgical instruments, wound care applications and more.
  • A novel nylon is malleable yet retains its shape, offering an imaging-ready replacement for flexible metals in applications such as splints.
  • The Acteev MED and HiDura MED teams will exhibit at Booth 673 across from the MedTech Theater at MD&M West from February 6-8, 2024.

SyBridge Technologies to Participate in MD&M West

Retrieved on: 
Thursday, February 1, 2024
MD, Catheter, Development, Syringe, Medical device

ITASCA, Ill., Feb. 1, 2024 /PRNewswire/ -- SyBridge Technologies, a global leader in design, tooling, and manufacturing, today announced that they will be participating at MD&M West to showcase its unparalleled ability to support every stage of the medical device lifecycle, from concept to product launch.

Key Points: 
  • ITASCA, Ill., Feb. 1, 2024 /PRNewswire/ -- SyBridge Technologies, a global leader in design, tooling, and manufacturing, today announced that they will be participating at MD&M West to showcase its unparalleled ability to support every stage of the medical device lifecycle, from concept to product launch.
  • Notably, SyBridge VP of Innovation, Research & Development Dr. Charlie Wood will be introducing the MD&M West keynote panel with a focus on Terrestrial Innovations in Quality Assurance for Space-Age Product.
  • MD&M West is the perfect stage to highlight how SyBridge is not just shaping the present, but propelling the industry towards a more efficient, innovative, and limitless future," says Dr. Charlie Wood, VP of Innovation, Research & Development at SyBridge Technologies.
  • MD&M West participants can visit SyBridge at booth #3943, where the company will be showcasing how it is pushing the boundaries of what is possible, ensuring exceptional precision, supporting greater manufacturing output, and helping brands reduce their overall costs.

MemorialCare Launches New Women's Heart Center and Recruits Nissi Suppogu, M.D. as Medical Director - Creating Sub-Specialized Women's Heart Health Center in Community

Retrieved on: 
Thursday, February 1, 2024
Cardiology, Anxiety, Microangiopathy, Hypertension, Long Beach Medical Center, Family, Artery, Obesity, Heart, Chronic pain, Cardiovascular disease, Gestational diabetes, Research, Exercise, Patient, Splenic infarction, Diagnosis, Scar, Friends, Autoimmune disease, Chest pain, Catheter, Depression, Pregnancy, Neck, Physician, Vasospasm, Diabetes, Dizziness, Education, Risk, Menopause, Smoking, Blood, Rest, Health, Place of birth, Fatigue, Human, Rehabilitation

FOUNTAIN VALLEY, Calif., Feb. 1, 2024 /PRNewswire/ -- MemorialCare, a prominent nonprofit Southern California integrated health system, has announced the launch of the Women's Heart Center at the MemorialCare Heart & Vascular Institute – a specialized center dedicated solely to expertise in education, prevention, early diagnosis, and timely management of women-specific cardiac presentations across their lifespan. The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group, with future plans to expand to additional MemorialCare sites in Orange County.

Key Points: 
  • The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group , with future plans to expand to additional MemorialCare sites in Orange County.
  • To lead a dynamic and distinctive program such as this, MemorialCare has recruited and appointed Nissi Suppogu, M.D.
  • as the medical director of the Women's Heart Center.
  • Dr. Suppogu is fellowship trained, meaning she has two years of additional sub-specialty training and education in women's heart health.

InventHelp Inventor Develops New Garment Line for Patients with IVs & Ports (CHK-952)

Retrieved on: 
Wednesday, January 24, 2024
Patient, Multimedia, Intravenous therapy, Sale, Suite, Dialysis, Catheter, Fistula, GRAY, ACCESS

View original content to download multimedia:https://www.prnewswire.com/news-releases/inventhelp-inventor-develops-ne...

Key Points: 
  • I wanted to create attire that outpatients could wear to dialysis and other treatments," said an inventor, from Blue Island, Ill., "so I invented GRAY'S ACCESS.
  • My design would provide added comfort while ensuring access to the anterior arm for ports, fistulas, or catheters."
  • The invention provides a new garment specifically designed for patients with IVs.
  • It also increases comfort and warmth for the patient and it eliminates the need to remove or reposition clothing items.